Related Experiment Videos
Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line
F Carlomagno1, D Salvatore, M Santoro
1Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli, Naples, Italy.
Abstract:
The RET proto-oncogene encodes a tyrosine-kinase receptor specifically expressed in tissues of neuroectodermal origin. Recently specific point mutations of RET have been demonstrated to be responsible for the Multiple Endocrine Neoplasia type 2A and 2B and Familial Medullary Thyroid Carcinoma syndromes, characterized by the occurrence of medullary thyroid carcinomas. Here we report that a human medullary thyroid carcinoma cell line, the TT cell line, harbours a MEN2A-type mutation, specifically a cysteine to triptophan substitution at the level of the RET codon 634. This mutation is heterozygous and both normal and mutated alleles are expressed. We suggest that the TT cell line could be a useful cell system to investigate the role played by the RET oncogene in the transformation and differentiation of human thyroid C-cells.
Insights
A specific RET gene mutation, linked to Multiple Endocrine Neoplasia syndromes, was found in the TT medullary thyroid carcinoma cell line. This finding offers a new model for studying RET oncogene roles in thyroid cancer progression.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- The RET proto-oncogene is crucial in neuroectodermal tissues.
- RET mutations cause Multiple Endocrine Neoplasia types 2A/2B and Familial Medullary Thyroid Carcinoma.
- Medullary thyroid carcinomas (MTCs) are associated with these RET-driven syndromes.
Purpose of the Study:
- To characterize the RET gene status in the human MTC cell line, TT.
- To investigate the potential of the TT cell line as a model for MTC research.
Main Methods:
- Genetic analysis of the TT cell line.
- Identification of specific RET proto-oncogene mutations.
- Assessment of allele expression.
Main Results:
- The TT cell line harbors a MEN2A-type RET mutation (Cys634Trp).
- This mutation is heterozygous, with both normal and mutated alleles expressed.
- The TT cell line provides a relevant model for studying RET in MTC.
Conclusions:
- The TT cell line carries a clinically relevant RET mutation.
- This cell line is a valuable tool for understanding RET oncogene function in thyroid C-cell transformation and differentiation.